Feds push states to abolishcertificate of need regs

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 30 No 12
Volume 30
Issue 12

The U.S. Department of Justice and theFederal Trade Commission are pressuring stategovernments to repeal certificate of need lawsmeant to control healthcare costs by regulatingthe purchase of capital equipment, suchas MRI technology and CT scanners.

The U.S. Department of Justice and the Federal Trade Commission are pressuring state governments to repeal certificate of need laws meant to control healthcare costs by regulating the purchase of capital equipment, such as MRI technology and CT scanners.

The two agencies argue that CON laws are anticompetitive, favor incumbents, and undercut consumer choice. The DOJ and FTC underscored their position in discussions with Georgia and in statements to Alaska, Florida, and, more recently, Illinois.

At the invitation of Gov. Sarah Palin of Alaska, FTC officials testified in February at a state legislative committee in favor of HB 337, a bill that would have eliminated CON jurisdiction in several cities and towns. The bill's opponents say deregulation will favor privately owned specialty hospitals at the expense of the state's acute care hospitals. Efforts to pass the bill have so far been stymied.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.